alpha-melanocyte stimulating hormone (alpha-MSH) is an important regulator of food intake, metabolic rate, and inflammation. Recently, alpha-MSH was shown to influence sympathetic activity and blood pressure regulation. In the present study, we investigated the cardiovascular effects of alpha-MSH in the nucleus tractus solitarii (NTS) of spontaneously hypertensive rats (SHR). Because nitric oxide (NO) is well-known to involve in central cardiovascular regulation, we elucidated the role of NO in the cardiovascular responses induced by alpha-MSH. In urethane-anesthetized SHR, unilateral microinjection of alpha-MSH (0.3-300 pmol) into the NTS produced dose-responsive depressor and bradycardic effects. The cardiovascular effects of alpha-MSH were abrogated by the antagonist of melanocortin receptor (MC3/4-R), SHU9119. Pretreatment with precursor of nitric oxide, L-arginine, enhanced the duration of alpha-MSH-mediated hypotensive effects, whereas prior application of L-NAME, a universal inhibitor of nitric oxide synthase (NOS), significantly attenuated the effects of alpha-MSH. Prior injection with inhibitor of inducible NOS, aminoguanidine, but not inhibitor of neuronal NOS, 7-nitroindazole, attenuated the hypotensive effect of alpha-MSH. In summary, these results indicated alpha-MSH induced depressor and bradycardic effects in the NTS of SHR. Besides, the hypotensive mechanism of alpha-MSH was mediated via MC4-R and involved with iNOS activation in the NTS of SHR.

The central nervous system (CNS) melanocortin signaling pathway plays a critical role in the regulation of metabolism. However, the regulatory effects of CNS melanocortin signaling on hepatic lipid metabolism and fatty liver disease have not been well established. Although the activity of the CNS melanocortin system is regulated by metabolic signals, the mechanism for this regulation is not fully understood. Variants of the FTO (fat mass and obesity-associated) gene are associated with obesity and FTO is expressed in the hypothalamic neurons including proopiomelanocortin (POMC) neurons. Therefore, it is hypothesized that hypothalamic FTO plays a role in the regulation of metabolism by mediating the effect of metabolic signals on hypothalamic melanocortinergic neurons, and that impairments in this regulation may cause metabolic impairments including obesity and fatty liver disease. Intracerebroventricular (i.c.v.) treatment with SHU9119, a melanocortin antagonist, increased hepatic lipid accumulation and the expression of genes encoding lipogenic enzymes in lean mice. Conversely, i.c.v. treatment with MTII, a melanocortin agonist, reduced the expression of hepatic lipogenic genes in association with reduction in body weight in ob/ob mice, a mouse model of fatty liver disease. Immunohistochemical analysis demonstrated that Fto is co-expressed in both POMC and agouti-related protein (AgRP) neurons in the mouse hypothalamus. Fto mRNA and protein expression was reduced by fasting and increased by glucose treatment in nutritionally important hypothalamic nuclei. Fasting-induced reduction in hypothalamic Fto expression was observed in both lean wild-type and obese ob/ob mice, while the stimulatory effect of glucose on hypothalamic Fto expression was absent in ob/ob mice. These findings support the hypothesis that central melanocortin signaling regulates hepatic lipid metabolism in part by regulating de novo lipogenesis. Impairments in the central melanocortin signaling lead to the development of hepatic steatosis, while enhanced melanocortin signaling may be beneficial in reversing abnormal hepatic lipid metabolism in fatty liver disease (Poritsanos et al., 2008). These findings also support the hypothesis that Fto is expressed in the hypothalamic melanocortinergic neurons and is regulated by metabolic signals involving changes in CNS glucose availability and/or glucose action. Impairments in this regulation may cause metabolic impairments including obesity and fatty liver disease.

Objective: Description of the clinical, biochemical and genetic features of a Polish patient with familial glucocorticoid deficiency. Methods: Detailed clinical investigation, hormonal analysis and sequencing of the coding region of the melanocortin 2 receptor (MC2R) gene in this patient. Results: We report on a 3-month-old boy with familial glucocorticoid deficiency who presented at the age of 3 months with skin hyperpigmentation, muscle weakness, mild jaundice and constipation. Hormonal analyses revealed high ACTH and TSH serum concentrations, low serum cortisol concentration along with normal blood electrolytes. On hydrocortisone supplementation, the disease symptoms disappeared and the child recovered completely. His physical and mental development progresses normally. Genetic analysis disclosed a novel compound heterozygous MC2R mutation p.Leu46fs and p.Val49Met. Conclusion: The heterozygous p.Leu46fs mutation adds to the small number of MC2R nonsense mutations and is the first frameshift mutation within the first transmembrane domain of the receptor. According to molecular modeling the Val49Met mutation results in a structural change of the first transmembrane domain and in a potential novel interaction of the transmembrane domains I and VII. / Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.

The central nervous system (CNS) melanocortin signaling pathway plays a critical role in the regulation of metabolism. However, the regulatory effects of CNS melanocortin signaling on hepatic lipid metabolism and fatty liver disease have not been well established. Although the activity of the CNS melanocortin system is regulated by metabolic signals, the mechanism for this regulation is not fully understood. Variants of the FTO (fat mass and obesity-associated) gene are associated with obesity and FTO is expressed in the hypothalamic neurons including proopiomelanocortin (POMC) neurons. Therefore, it is hypothesized that hypothalamic FTO plays a role in the regulation of metabolism by mediating the effect of metabolic signals on hypothalamic melanocortinergic neurons, and that impairments in this regulation may cause metabolic impairments including obesity and fatty liver disease. Intracerebroventricular (i.c.v.) treatment with SHU9119, a melanocortin antagonist, increased hepatic lipid accumulation and the expression of genes encoding lipogenic enzymes in lean mice. Conversely, i.c.v. treatment with MTII, a melanocortin agonist, reduced the expression of hepatic lipogenic genes in association with reduction in body weight in ob/ob mice, a mouse model of fatty liver disease. Immunohistochemical analysis demonstrated that Fto is co-expressed in both POMC and agouti-related protein (AgRP) neurons in the mouse hypothalamus. Fto mRNA and protein expression was reduced by fasting and increased by glucose treatment in nutritionally important hypothalamic nuclei. Fasting-induced reduction in hypothalamic Fto expression was observed in both lean wild-type and obese ob/ob mice, while the stimulatory effect of glucose on hypothalamic Fto expression was absent in ob/ob mice. These findings support the hypothesis that central melanocortin signaling regulates hepatic lipid metabolism in part by regulating de novo lipogenesis. Impairments in the central melanocortin signaling lead to the development of hepatic steatosis, while enhanced melanocortin signaling may be beneficial in reversing abnormal hepatic lipid metabolism in fatty liver disease (Poritsanos et al., 2008). These findings also support the hypothesis that Fto is expressed in the hypothalamic melanocortinergic neurons and is regulated by metabolic signals involving changes in CNS glucose availability and/or glucose action. Impairments in this regulation may cause metabolic impairments including obesity and fatty liver disease.

No description available.

Tesis por compendio / [ES] El sistema de melanocortina es una estructura clave en la regulación de una amplia gama de funciones fisiológicas que incluyen la melanogénesis, la respuesta al estrés y el equilibrio energético, mediante la unión a una familia de receptores acoplados a la proteína G específicos (MC1R-MC5R). La sobreexpresión de agonistas inversos, la proteína de señalización agutí (Asip) y la proteína relacionada con agutí (Agrp) da como resultado un aumento de la ingesta de alimentos, de crecimiento lineal y de peso corporal. Asip regula la polaridad de pigmentación dorsoventral a través del MC1R, y la sobreexpresión induce obesidad en ratones al unirse al Mc4r central. La sobreexpresión de asip1 en el pez cebra transgénico (asip1-Tg) mejora el crecimiento, sin afectar la acumulación lipídica (obesidad), incluso cuando se alimentan bajo regímenes inductores severos. Los peces asip1-Tg no necesitan comer más para crecer más y más rápido, lo que sugiere una mayor eficiencia alimentaria. Además, los peces asip1-Tg criados en alta densidad son capaces de crecer mucho más que los peces de tipo salvaje (WT) criados en baja densidad, aunque los peces asip1-Tg parecen ser más sensibles al estrés por hacinamiento que los peces WT. El análisis transcriptómico comparativo del intestino de asip1-Tg refleja una expresión diferencial de transportadores aminoácidicos, monocarboxilatos, transportadores iónicos y de vitaminas. La sobreexpresión reduce la integridad del epitelio intestinal aumentando su permeabilidad paracelular y potencia el transporte electrogénico de aminoácidos. Así, los peces transgénicos poseen mayor capacidad para la absorción de nutrientes y, por extensión una mejora en la eficiencia alimenticia que podría explicar, en parte, ese crecimiento diferencial bajo tasas de ingesta similares. Esta tesis tuvo también como objetivo investigar si los asip1-Tg mantienen un fenotipo dominante asociado con una mayor tasa de alimentación. Los resultados muestran, por el contrario, un carácter reactivo/subordinado en los asip1-Tg que aboga por una participación del sistema de melanocortinas en la regulación del comportamiento de peces. El perfil subordinado de los animales asip1-Tg, junto con una activación del eje del estrés, sugiere que estos animales pueden mostrar un comportamiento de ansiedad. Los resultados indicaron que los peces asip1-Tg muestran un comportamiento de ansiedad que además relacionado con una severa disminución de los niveles centrales de serotonina (5HT) y dopamina y elevación de su recaptación neuronal y degradación. La administración de un inhibidor de la recaptación de 5HT, recupera el fenotipo comportamental salvaje, mitigando el comportamiento de ansiedad en los peces transgénicos y rescatando los niveles de 5HT. Esta ansiedad podría repercutir en una alteración del comportamiento locomotor de los animales, por ello estudiamos los ritmos circadianos de actividad locomotora. Los resultados muestran que los animales asip1-Tg exhiben una disrupción completa del ritmo de actividad, con una actividad muy elevada, especialmente durante la noche. Esta disrupción es concomitante con una desaparición del ritmo diario de serotonina y melatonina. Además, los resultados muestran una pérdida de ritmos de expresión de genes reloj (per1a y clock1a). La incubación, in vitro, de glándulas pineales con Asip1 produjo una inhibición de la secreción de melatonina replicando los resultados obtenidos in vivo y demostrando un efecto directo de Asip1, sobre la fisiología de la pineal. En esta tesis, se utilizó el pez cebra como modelo para investigar los efectos de la obesidad sobre la ansiedad y la memoria. La obesidad no tuvo ningún efecto sobre la ansiedad, pero produjo una disminución de la memoria a corto plazo, estudiada mediante test de condicionamiento aversivo. Este estudio proporciona, un protocolo fiable para evaluar el efecto de las enfermedades metabólica en la función cognitiva y conductual. / [CA] El sistema de melanocortina és una estructura clau en la regulació d'una ampla gamma de funcions fisiològiques que inclouen la melanogènesi, la resposta a l'estrès i l'equilibri energètic, mitjançant la unió a una família de receptors acoblats a la proteïna G específics (MC1R-MC5R). La sobreexpressió d'agonistes inversos, la proteïna de senyalització agutí (Asip) y la proteïna relacionada con agutí (Agrp) dona com a resultat un augment de la ingesta d'aliments, de creixement lineal i de pes corporal. Asip regula la polaritat de pigmentació dors-ventral a través del MC1R, y la sobreexpressió indueix obesitat en ratolins en unir-se al MC4R central. La sobreexpressió de asip1 en el peix zebra transgènic (asip1-Tg) millora el creixement, sense afectar l'acumulació lipídica (obesitat), inclús quan s'alimenten sota règims inductors severs. Los peces asip1-Tg no necessiten menjar més per a créixer més i més ràpid, lo qual suggereix una major eficiència alimentària. A més a més, els peixos asip1-Tg criats en alta densitat són capaces de créixer molt més que els peixos de tipus salvatge (WT) criats en baixa densitat, malgrat que els peixos asip1-Tg semblen ser més sensibles a l'estrès per amuntegament que els peixos WT. L'anàlisi transcriptòmic comparatiu de l'intestí de asip1-Tg reflecteix una expressió diferencial de transportadors aminoacídics, monocarboxilats, transportadors iònics i de vitamines. La sobreexpressió redueix la integritat de l'epiteli intestinal augmentant la seua permeabilitat paracel·lular i potencia el transport electrogènic d'aminoàcids. Per tant, els peixos transgènics posseeixen major capacitat per l'absorció de nutrients i, per extensió una millora en la eficiència alimentària que podria explicar, en part, eixe creixement diferencial sota taxes d'ingesta similars. Aquesta tesi tingué també com a objectiu investigar si els asip1-Tg mantenien un fenotip dominant associat amb una major taxa d'alimentació. Els resultats mostren, pel contrari, un caràcter reactiu/subordinat en los asip1-Tg que advoca per una participació del sistema de melanocortines en la regulació del comportament de peixos. El perfil subordinat dels animals asip1-Tg, junt amb una activació de l'eix de l'estrès, suggereix que aquests animals poden mostrar un comportament d'ansietat. Els resultats indicaren que els peixos asip1-Tg mostren un comportament d'ansietat relacionat amb una severa disminució dels nivells centrals de serotonina (5HT) i dopamina i elevació de la seua recaptació neuronal i degradació. L'administració de un inhibidor de la recaptació de 5HT recupera el fenotip comportamental salvatge, mitigant el comportament d'ansietat en els peixos transgènics i rescatant els nivells centrals de 5HT. Esta ansietat podria repercutir en una alteració del comportament locomotor dels animals, per la qual cosa vam estudiar els ritmes circadians d'activitat locomotora. Els resultats mostren que els animals asip1-Tg exhibeixen una disrupció completa del ritme d'activitat, amb una activitat molt elevada durant tot el cicle diari, especialment durant la nit. Esta disrupció es concomitant amb una desaparició del ritme diari de serotonina i melatonina. A més a més, els resultats mostren una pèrdua de ritmes de expressió de gens rellotge (per1a y clock1a). La incubació, in vitro, de glàndules pineals con Asip1 va produir una inhibició de la secreció de melatonina replicant els resultats obtinguts in vivo y demostrant un efecte directe de Asip1 sobre la fisiologia de la pineal. En esta tesi, se va utilitzar el peix zebra com a model per investigar els efectes de la obesitat sobre la ansietat i la memoria. L'obesitat no va tindre cap efecte sobre l'ansietat, però va produir una disminució de la memòria a curt termini, estudiada mitjançant tests de condicionament aversiu. Aquest estudi proporciona, un protocol fiable per a avaluar l'efecte de les malalties metabòliques en la funció cognitiva i conductual. / [EN] The melanocortin system plays a key role in the regulation of a wide range of physiological functions including melanogenesis, stress response and energy balance, through binding to a family of specific G protein-coupled receptors (MC1R-MC5R). Overexpression of inverse agonists, agouti-signalling protein (Asip) and agouti-related protein (Agrp) results in increased food intake, linear growth and body weight. Asip regulates dorso-ventral pigmentation polarity through MC1R, and over-expression induces obesity in mice by binding to the central MC4R. Overexpression of asip1 in transgenic zebrafish (asip1-Tg) enhances growth, without affecting lipid accumulation (obesity), even when fed under severe inducing regimens. The asip1-Tg fish do not need to eat more to grow bigger and faster, suggesting increased feed efficiency. In addition, asip1-Tg fish reared at high density are able to grow much larger than wild-type (WT) fish reared at low density, although asip1-Tg fish appear to be more sensitive to overcrowding stress than WT fish. Comparative transcriptomic analysis of asip1-Tg gut reflects differential expression of amino acid, monocarboxylate, ionic and vitamin transporters. Overexpression reduces the integrity of the intestinal epithelium by increasing its paracellular permeability and enhances electrogenic amino acid transport. Thus, transgenic fish possess a greater capacity for nutrient absorption and, by extension, an improvement in feed efficiency that could explain, in part, this differential growth under similar intake rates. This thesis also aimed to investigate whether asip1-Tg maintain a dominant phenotype associated with a higher feeding rate. Experimental results show, on the contrary, a reactive/subordinate character in asip1-Tg which argues for an involvement of the melanocortin system in the regulation of fish behaviour. Improving feeding motivation without promoting aggression in fish, thus avoiding the threat to native populations in case of an escape, makes the inhibition of the melanocortin system, through the overexpression of asip1, a feasible target for the development of genetically modified lines. The subordinate profile of the asip1-Tg animals, together with an activation of the stress axis, suggests that these animals may exhibit anxiety-like behaviour. The results indicated that asip1-Tg fish show a behaviour similar to our concept of anxiety related to a severe decrease in central serotonin (5HT) and dopamine levels as well as the elevation of their neuronal reuptake and degradation. The administration of fluoxetine, a serotonin reuptake inhibitor, recovers the wild-type behavioural phenotype, mitigating anxiety behaviour in transgenic fish and restoring central 5HT levels. This anxiety could have repercussions on the locomotor behaviour of the animals, so we studied circadian rhythms of locomotor activity. The results show that asip1-Tg animals exhibit a complete disruption of the activity rhythm, with very high activity levels throughout the daily cycle, especially during the night. This disruption is concomitant with a disappearance of the daily rhythm of serotonin and melatonin. In addition, the results show a loss of clock gene expression rhythms (per1a and clock1a). Incubation, in vitro, of pineal glands with Asip1 produced an inhibition of melatonin secretion replicating the results obtained in vivo and demonstrating a direct effect of Asip1 on pineal physiology. In this PhD thesis, zebrafish was used as a model to investigate the effects of overfeeding-induced obesity on anxiety-like behaviour and memory. Obesity had no effect on anxiety, but produced a decrease in short-term memory, studied by means of aversive conditioning tests. This study also provides a reliable protocol for assessing the effect of metabolic diseases on cognitive and behavioural function, supporting zebrafish as a model for cognitive and behavioural neuroscience. / Esta tesis ha sido realizada a través del programa de ‘Ayudas para la formación de personal investigador’ (FPI) BES‐2017‐082424 de la Agencia Estatal de Investigación, en Instituto de Acuicultura Torre de la Sal (IATS) del Consejo Superior de Investigaciones Científicas (CSIC) en el Grupo de investigación de Control de la Ingesta en Peces dirigido por José Miguel Cerdá Reverter, director de esta tesis. Los trabajos llevados a cabo en esta tesis han sido financiados por Ministerio de Ciencia, Innovación y Universidades (MICIU) a través de los siguientes proyectos: MELANOCONDUCT: Implicación del sistema de melanocortinas en la regulación de los mecanismos temporales y conductuales de peces AGL2016-74857-C3-3-R; Cronopeces: Red temática de cronobiología de peces y sus aplicaciones en acuicultura RED2018-102487-T; MacForFish: Nuevos aspectos homeostáticos y comportamentales de la regulación de la ingesta en peces PID2019-103969RB-C33; FISHTASTE: Implicación de los mecanismos sensoriales del gusto en la regulación de la ingesta de peces - Involvement of taste sensing mechanisms in the regulation of feed intake of fish PID2022-136288OB-C33 / Godino Gimeno, A. (2024). Involvement of the Melanocortin System in the Regulation of Circadian and Behavioural Mechanisms in Zebrafish [Tesis doctoral]. Universitat Politècnica de València. https://doi.org/10.4995/Thesis/10251/203148 / Compendio

Das Körpergewicht und die Nahrungsaufnahme werden unter anderem vom Hypothalamus reguliert. Dort werden Hormonelle Signale der Peripherie und neuronale Signale integriert. Die G-Protein gekoppelten Melanocortinrezeptoren 3 und 4 (MC3R und MC4R) werden von ihren Agonisten, den Melanocortinen aktiviert und durch den inversen Agonisten/Antagonisten Agouti-Related Peptide (AgRP) inaktiviert. Als weiterer Downstream-Mediatoren der MC4R-Aktivierung wurden kürzlich Brain Derived Neurotrophic Factor (BDNF) und dessen Rezeptor TrkB (Tropomyosin-Related –Kinase) identifiziert. Mutationen im MC4R gelten als häufigste monogenetische Ursache für Adipositas. Da viele dieser Mutationen aber in vitro funktionell nicht relevant sind, wurde ein Amosäurevergleich von orthologen MC4R aus 70 verschiedenen Spezies erstellt. Funktionsverlustmutationen waren häufiger an koservierten Positionen, während Mutationen ohne Effekt überwiegend an schwach konservierten Positionen zu finden waren. Funktionelle Charakterisierung der von in Mausmodellen identifizierten Punktmutationen I194F und Y302C ergaben eine gute in-vivo/in-vitro Korrelation. Desweiteren wurden in der Normalbevölkerung in normalgewichtigen Personen identifizierte MC4R-Punktmutationen funktionell charakterisiert. Die Mutationen R7C, A70T, T112K, Q156R, M200V, V166I und R236H hatten keinen Effekt auf die Rezeptorfunktion, die H158R. Mutation zeigte eine hohe Basalaktivität, die aber durch AgRP erniedrigt werden konnte. Die in adipösen Patienten gefundenen Mutationen S136F und S139R wiesen einen kompletten Funktionsverlust auf, erstere verursachte zudem sogar einen dominant-negativen Effekt bei Koexpression mit dem Wildtyprezeptor. Für den MC3R wurde das zum Translationsstart bevorzugte Startcodon identifiziert. Für die Rezeptortyrosinkinase TrkB konnte in Hefe-2-Hybridscreens der neue Interaktionspartner Sept3 identifiziert werden. Dieses Protein bindet phosphorylierungsunabhängig an die intrazelluläre Juxtamembrandomäne. / Bodyweight and food intake are regulated by the hypothalamus which integrates peripheral hormonal and neural signals. The G-protein-coupled melanocortin-receptors 3 and 4 (MC3R and MC4R) are activated by melanocortins or inhibited by agouti-related pepetide (AgRP) and signal via the cAMP pathway. Brain-derived neurotrophic Factor (BDNF) was recently shown to signal downstream the MC4R via its receptor TrkB (tropomyosin-related kinase). Mutations in the MC4R are the most common cause of monogenetic obesity. However, many of these mutations are not functionally relevant in vitro. Here, an amino acid alignment of orthologous MC4R from over 70 species was used to evaluate reported mutations. Loss-of-function mutations were predominantly located at highly conserved positions whereas mutations without effect were located at non-conserved positions. Functional characterization of MC4R point mutations I194F (partial loss of function) and Y302C (complete loss of function) identified in mouse models showed good in vitro/in vivo correlation. Furthermore mutations found in normal weight persons were characterized: R7C, A70T, T112K, Q156K, M200V, V166I and R236H had no effect on receptor function in vitro, whereas the H158R Mutation showed high constitutive activity, which however could be diminished by AgRP. The mutations S136F and S139F identified in obese patients were characterized as complete loss-of-function mutations, the former additionally caused a dominant-negative effect on wildtype MC4R in vitro. For the MC3R the preferred start-codon for initiation of translation was identified. For TrkB Sept3 could be identified as a new interaction partner in a yeast-2-hybrid screen. This Protein belonging to the septin family binds to the intracellular juxtamembrane domain of TrkB independent of phosphorylation of the Shc-binding site.

Malignant cutaneous melanoma is the deadliest form of skin cancer, and a majority of melanoma diagnoses are a result of exposure to ultraviolet (UV) radiation. UV radiation causes DNA damage, which if not repaired correctly via nucleotide excision repair (NER) can result in mutations and melanomagenesis. The melanocortin 1 receptor (MC1R) is a Gs protein coupled receptor located on melanocyte plasma membranes and is involved in protecting the skin from UV induced damage. MC1R signaling results in the activation of two protective pathways: 1) induction of eumelanin synthesis downstream of micropthalmia-associated transcription factor (MITF) and 2) acceleration of NER downstream of ataxia telangiectaseia mutated and Rad3 related (ATR). MC1R signaling, however, also promotes melanocyte proliferation, therefore, the activation of the MC1R pathway must be regulated. The overall hypothesis of this dissertation is that the pathways downstream of MC1R can be manipulated to protect against UV induced damage. Chapter 2 investigates the regulation of the MC1R neutral antagonist human β-defensin 3 (βD3). UV damage did not induce βD3 mRNA expression in ex vivo human skin explants. The induction of βD3 expression instead correlated with inflammatory cytokines including TNF. Chapter 3 investigates the interdependence and cross talk between the two protective pathways downstream of MC1R. We directly tested the effect of MITF on the acceleration of NER and the effect of ATR on the induction of eumelanin synthesis following MC1R activation. MITF was not required for the acceleration of NER as mediated by ATR, however, the induction of transcription of enzymes involved in eumelanin synthesis was dependent upon ATR kinase activity. Finally, Chapter 4 investigates the mechanism by which MC1R promoted proliferation and whether the two UV protective pathways downstream of MC1R could be selectively activated without the risk of melanocyte proliferation. MC1R signaling resulted in activation of the mechanistic target of rapamycin complex 1 (mTORC1), a major regulator of cell growth and proliferation. Inhibition of mTORC1 signaling via rapamycin prevented MC1R induced proliferation in vitro. Rapamycin, however, did not prevent MC1R induced eumelanin synthesis or the acceleration of NER in vitro or in vivo suggesting it is possible to selectively activate the beneficial signaling pathways without the risk of melanocyte proliferation. The results of this dissertation suggest that MC1R signaling could be augmented in individuals to prevent UV induced damage.

INTRODUÇÃO: O aumento mundial da prevalência de obesidade atribui-se principalmente a mudanças nos hábitos alimentares e na prática de atividade física, que afetam indivíduos predispostos geneticamente. Alterações genéticas podem provocar desequilíbrio na regulação homeostática afetando sinalizadores periféricos e centrais. Um componente do controle central fica no núcleo arqueado hipotalâmico, sendo o receptor tipo 4 de melanocortina (MC4R) de suma importância. Mutações no MC4R têm sido relatadas como causa mais frequente de obesidade monogênica. Há evidência de que polimorfismos de nucleotídeo único (SNP) localizados próximos ao MC4R possam estar relacionados ao aumento do risco para obesidade, porém estudos de variantes nesse gene avaliando o consumo alimentar são escassos e controversos. OBJETIVO: Avaliar a influência de variantes alélicas no MC4R sobre consumo alimentar, presença de compulsão alimentar periódica (CAP), composição corporal e perfil clínico e metabólico em crianças e adolescentes obesos. MÉTODOS: Trata-se de um estudo transversal realizado com crianças e adolescentes obesos. Foram avaliados parâmetros antropométricos, metabólicos e fatores de risco cardiometabólicos, incluindo hipertensão arterial sistêmica, glicemia de jejum alterada, hipertrigliceridemia e HDL-colesterol baixo. A CAP foi avaliada utilizando a Escala de Compulsão Alimentar Periódica e o consumo alimentar por meio do Recordatório de 24 horas, analisando consumo calórico total, percentual de macronutrientes e fibras, além da frequência na omissão do café da manhã, adequação de macronutrientes, frações lipídicas e colesterol. Para verificar o efeito dos SNPs no risco para a obesidade foi incluído um grupo controle composto por 137 crianças e adolescentes eutróficos. Foi realizado o sequenciamento do gene MC4R e a genotipagem por PCR em tempo real das variantes rs17782313 e rs12970134, adotando-se o modelo recessivo para a análise. A análise estatística para comparação dos grupos foi conduzida por meio dos Testes T de Student ou Mann-Whitney U. Para avaliar a magnitude do risco, foi realizada regressão logística ajustada para Z-IMC, idade e gênero, com o nível de significância fixado em 0,05. RESULTADOS: Foram incluídos no estudo 536 obesos (52,1% meninas; 12,7 ± 2,7 anos; Z-IMC 3,24 ± 0,57). A frequência dos SNPs foi semelhante entre os grupos de obesos e controle. Os portadores do polimorfismo rs17782313 apresentaram maior nível de triglicérides (108 ± 48 vs.119 ± 54, p=0,034)e maior risco para hipertrigliceridemia (OR=1,985; IC95% 1,288-3,057; p=0,002). Não houve associação do rs12970134 com os parâmetros clínicos, metabólicos ou alimentares. No gene MC4R foram identificados 10 polimorfismos já descritos e uma variante nova, Asn72Ser (A/G), sendo 8 mutações do tipo missense e 3 sinônimas. CONCLUSÕES: Os SNPs rs17782313 e rs12970134 não influenciam o consumo alimentar nem a presença da CAP. O SNP rs17782313 está associado a maior risco de hipertrigliceridemia e maior nível sérico de triglicérides em crianças e adolescentes obesos. A presença de mutações que resultem na perda de função no gene MC4R é rara nessa coorte / INTRODUCTION: The global increase in the prevalence of obesity is attributed mainly to changes in dietary habits and physical activity, which affects genetically predisposed individuals. Genetic alterations can cause imbalance in the homeostatic regulation affecting peripheral and central signals. One component of the central control is the arcuate nucleus of the hypothalamus, and the melanocortin type 4 receptor (MC4R) is of outstanding importance. Mutations in MC4R have been reported as the most frequent cause of monogenic obesity. Studies indicate that polymorphisms located near the MC4R may be related to increased risk for obesity, but the studies of variations in this gene and its relation to food intake are scarce and controversial. OBJECTIVE: To evaluate the influence of allelic variants of MC4R in food intake, binge eating behavior (BE), body composition, clinical and metabolic profile in obese children and adolescents. METHODS: This is a cross-sectional study with obese children and adolescents. Anthropometric, metabolic parameters and cardiometabolic risk factors including hypertension, impaired fasting glucose, hypertriglyceridemia and low HDL-cholesterol were evaluated. The BE was evaluated through the Binge Eating Scale, and to analyze the dietary intake 24 hour recall was used, evaluating total caloric intake, percentage of macronutrients, fiber, omission of breakfast, adequacy of macronutrients, lipid fractions and cholesterol. To investigate the effect of SNPs on obesity risk, a control group of 137 eutrophic children and adolescents was enrolled. The MC4R gene was sequenced and genotyping was performed by real-time PCR of the variants rs17782313 and rs12970134, adopting the recessive model for the analysis. Statistical analysis for group comparison was conducted using the Student T test or Mann-Whitney U test. To assess the magnitude of risk, logistic regression adjusted for Z-BMI, age and gender was performed, with the significance level of 0.05. RESULTS: The study included 536 subjects (52.1% girls, 12.7 ± 2.7 years-old, Z-BMI = 3.24± 0,57). The frequency of SNPs was similar between the obese and control groups. The C allele carriers for the rs17782313 polymorphism had increased triglyceride levels (108 ± 48 vs.119 ± 54, p = 0.034) and increased risk of hypertriglyceridemia (OR = 1.985, 95% CI 1.288-3.057, p = 0.002). There was no association of the SNP rs12970134 with clinical, metabolic or nutritional parameters. Ten polymorphisms already described and a new variant, Arn72Ser (A/G), were identified in the MC4R gene, with 8 missense mutations and 3 synonymous. CONCLUSIONS: The SNPs rs17782313 and rs12970134 did not influence food intake or the presence of BE. The SNP rs17782313 is associated with increased risk of elevated triglycerides and higher serum triglyceride levels in obese children and adolescents. The presence of mutations resulting in loss of function in the MC4R gene is rare in this cohort

INTRODUÇÃO: O aumento mundial da prevalência de obesidade atribui-se principalmente a mudanças nos hábitos alimentares e na prática de atividade física, que afetam indivíduos predispostos geneticamente. Alterações genéticas podem provocar desequilíbrio na regulação homeostática afetando sinalizadores periféricos e centrais. Um componente do controle central fica no núcleo arqueado hipotalâmico, sendo o receptor tipo 4 de melanocortina (MC4R) de suma importância. Mutações no MC4R têm sido relatadas como causa mais frequente de obesidade monogênica. Há evidência de que polimorfismos de nucleotídeo único (SNP) localizados próximos ao MC4R possam estar relacionados ao aumento do risco para obesidade, porém estudos de variantes nesse gene avaliando o consumo alimentar são escassos e controversos. OBJETIVO: Avaliar a influência de variantes alélicas no MC4R sobre consumo alimentar, presença de compulsão alimentar periódica (CAP), composição corporal e perfil clínico e metabólico em crianças e adolescentes obesos. MÉTODOS: Trata-se de um estudo transversal realizado com crianças e adolescentes obesos. Foram avaliados parâmetros antropométricos, metabólicos e fatores de risco cardiometabólicos, incluindo hipertensão arterial sistêmica, glicemia de jejum alterada, hipertrigliceridemia e HDL-colesterol baixo. A CAP foi avaliada utilizando a Escala de Compulsão Alimentar Periódica e o consumo alimentar por meio do Recordatório de 24 horas, analisando consumo calórico total, percentual de macronutrientes e fibras, além da frequência na omissão do café da manhã, adequação de macronutrientes, frações lipídicas e colesterol. Para verificar o efeito dos SNPs no risco para a obesidade foi incluído um grupo controle composto por 137 crianças e adolescentes eutróficos. Foi realizado o sequenciamento do gene MC4R e a genotipagem por PCR em tempo real das variantes rs17782313 e rs12970134, adotando-se o modelo recessivo para a análise. A análise estatística para comparação dos grupos foi conduzida por meio dos Testes T de Student ou Mann-Whitney U. Para avaliar a magnitude do risco, foi realizada regressão logística ajustada para Z-IMC, idade e gênero, com o nível de significância fixado em 0,05. RESULTADOS: Foram incluídos no estudo 536 obesos (52,1% meninas; 12,7 ± 2,7 anos; Z-IMC 3,24 ± 0,57). A frequência dos SNPs foi semelhante entre os grupos de obesos e controle. Os portadores do polimorfismo rs17782313 apresentaram maior nível de triglicérides (108 ± 48 vs.119 ± 54, p=0,034)e maior risco para hipertrigliceridemia (OR=1,985; IC95% 1,288-3,057; p=0,002). Não houve associação do rs12970134 com os parâmetros clínicos, metabólicos ou alimentares. No gene MC4R foram identificados 10 polimorfismos já descritos e uma variante nova, Asn72Ser (A/G), sendo 8 mutações do tipo missense e 3 sinônimas. CONCLUSÕES: Os SNPs rs17782313 e rs12970134 não influenciam o consumo alimentar nem a presença da CAP. O SNP rs17782313 está associado a maior risco de hipertrigliceridemia e maior nível sérico de triglicérides em crianças e adolescentes obesos. A presença de mutações que resultem na perda de função no gene MC4R é rara nessa coorte / INTRODUCTION: The global increase in the prevalence of obesity is attributed mainly to changes in dietary habits and physical activity, which affects genetically predisposed individuals. Genetic alterations can cause imbalance in the homeostatic regulation affecting peripheral and central signals. One component of the central control is the arcuate nucleus of the hypothalamus, and the melanocortin type 4 receptor (MC4R) is of outstanding importance. Mutations in MC4R have been reported as the most frequent cause of monogenic obesity. Studies indicate that polymorphisms located near the MC4R may be related to increased risk for obesity, but the studies of variations in this gene and its relation to food intake are scarce and controversial. OBJECTIVE: To evaluate the influence of allelic variants of MC4R in food intake, binge eating behavior (BE), body composition, clinical and metabolic profile in obese children and adolescents. METHODS: This is a cross-sectional study with obese children and adolescents. Anthropometric, metabolic parameters and cardiometabolic risk factors including hypertension, impaired fasting glucose, hypertriglyceridemia and low HDL-cholesterol were evaluated. The BE was evaluated through the Binge Eating Scale, and to analyze the dietary intake 24 hour recall was used, evaluating total caloric intake, percentage of macronutrients, fiber, omission of breakfast, adequacy of macronutrients, lipid fractions and cholesterol. To investigate the effect of SNPs on obesity risk, a control group of 137 eutrophic children and adolescents was enrolled. The MC4R gene was sequenced and genotyping was performed by real-time PCR of the variants rs17782313 and rs12970134, adopting the recessive model for the analysis. Statistical analysis for group comparison was conducted using the Student T test or Mann-Whitney U test. To assess the magnitude of risk, logistic regression adjusted for Z-BMI, age and gender was performed, with the significance level of 0.05. RESULTS: The study included 536 subjects (52.1% girls, 12.7 ± 2.7 years-old, Z-BMI = 3.24± 0,57). The frequency of SNPs was similar between the obese and control groups. The C allele carriers for the rs17782313 polymorphism had increased triglyceride levels (108 ± 48 vs.119 ± 54, p = 0.034) and increased risk of hypertriglyceridemia (OR = 1.985, 95% CI 1.288-3.057, p = 0.002). There was no association of the SNP rs12970134 with clinical, metabolic or nutritional parameters. Ten polymorphisms already described and a new variant, Arn72Ser (A/G), were identified in the MC4R gene, with 8 missense mutations and 3 synonymous. CONCLUSIONS: The SNPs rs17782313 and rs12970134 did not influence food intake or the presence of BE. The SNP rs17782313 is associated with increased risk of elevated triglycerides and higher serum triglyceride levels in obese children and adolescents. The presence of mutations resulting in loss of function in the MC4R gene is rare in this cohort